Ignite Creation Date:
2025-12-26 @ 5:17 PM
Ignite Modification Date:
2026-01-01 @ 12:34 AM
Study NCT ID:
NCT04923906
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-11-25
First Post:
2021-06-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Aumolertinib with or Without Chemotherapy As 1st Line Treatment in Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Sensitizing EGFR Mutations
Sponsor:
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-08-11
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-01-31
Completion Date Type:
ESTIMATED
First Submit Date:
2021-06-10
First Submit QC Date:
None
Study First Post Date:
2021-06-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-21
Last Update Post Date:
2024-11-25
Last Update Post Date Type:
ACTUAL